Glucomannan for abdominal pain-related functional gastrointestinal disorders in children: A randomized trial

World Journal of Gastroenterology

Volumn 19, Issue 20, 2013, Pages 3062-3068

  Horvath, Andrea ^a   Dziechciarz, Piotr ^a   Szajewska, Hania ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Abdominal painrelated functional gastrointestinal disorders; Children; Functional abdominal pain

Indexed keywords

DICOMAN JUNIOR; MALTODEXTRIN; MANNAN; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; EVENING DOSAGE; FACES PAIN SCALE; FEMALE; HUMAN; MALE; MORNING DOSAGE; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD;

EID: 84878247257     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i20.3062     Document Type: Article

References (31)

1. Saps M, Seshadri R, Sztainberg M, Schaffer G, Marshall BM, Di Lorenzo C. A prospective school-based study of abdominal pain and other common somatic complaints in children. J Pediatr 2009; 154: 322-326 [PMID: 19038403 DOI: 10.1016/ j.jpeds.2008.09.047]
2. Chiou E, Nurko S. Management of functional abdominal pain and irritable bowel syndrome in children and adolescents. Expert Rev Gastroenterol Hepatol 2010; 4: 293-304 [PMID: 20528117 DOI: 10.1586/egh.10.28]
3. Gawrońska A, Dziechciarz P, Horvath A, Szajewska H. A randomized double-blind placebo-controlled trial of Lactobacillus GG for abdominal pain disorders in children. Aliment Pharmacol Ther 2007; 25: 177-184 [PMID: 17229242 DOI: 10.1111/j.1365-2036.2006.03175.x]
4. Bausserman M, Michail S. The use of Lactobacillus GG in irritable bowel syndrome in children: a double-blind randomized control trial. J Pediatr 2005; 147: 197-201 [PMID: 16126049 DOI: 10.1016/j.jpeds.2005.05.015]
5. Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams JS, Staiano A, Walker LS. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology 2006; 130: 1527-1537 [PMID: 16678566 DOI: 10.1053/ j.gastro.2005.08.063]
6. Spiller RC. Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med 1999; 107: 91S-97S [PMID: 10588179 DOI: 10.1016/S0002-9343(99)00086-8]
7. Saps M, Pensabene L, Di Martino L, Staiano A, Wechsler J, Zheng X, Di Lorenzo C. Post-infectious functional gastrointestinal disorders in children. J Pediatr 2008; 152: 812-86, 816. e1 [PMID: 18492522]
8. de Vrese M, Schrezenmeir J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 2008; 111: 1-66 [PMID: 18461293 DOI: 10.1007/10_2008_097]
9. Huertas-Ceballos AA, Logan S, Bennett C, Macarthur C. Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev 2009; (1): CD003019 [PMID: 19160214]
10. Huertas-Ceballos A, Logan S, Bennett C, Macarthur C. Pharmacological interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database Syst Rev 2008; (1): CD003017 [PMID: 18254013]
11. Christensen MF. [Do bulk preparations help in cases of recurrent abdominal pain in children? A controlled study]. Ugeskr Laeger 1982; 144: 714-715 [PMID: 7048679 DOI: 10.1002/14651858. CD003019]
12. Feldman W, McGrath P, Hodgson C, Ritter H, Shipman RT. The use of dietary fiber in the management of simple, childhood, idiopathic, recurrent, abdominal pain. Results in a prospective, double-blind, randomized, controlled trial. Am J Dis Child 1985; 139: 1216-1218 [PMID: 2998181]
13. Chmielewska A, Horvath A, Dziechciarz P, Szajewska H. Glucomannan is not effective for the treatment of functional constipation in children: a double-blind, placebo-controlled, randomized trial. Clin Nutr 2011; 30: 462-468 [PMID: 21320737 DOI: 10.1016/j.clnu.2011.01.012]
14. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332 [PMID: 20332509 DOI: 10.1136/bmj.c332]
15. Tomlinson D, von Baeyer CL, Stinson JN, Sung L. A systematic review of faces scales for the self-report of pain intensity in children. Pediatrics 2010; 126: e1168-e1198 [PMID: 20921070 DOI: 10.1542]
16. Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment Pharmacol Ther 2009; 29: 508-518 [PMID: 19053980 DOI: 10.1111/j.1365-2036.2008.03911.x]
17. Roberfroid M. Prebiotics: the concept revisited. J Nutr 2007; 137: 830S-837S [PMID: 17311983]
18. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 1995; 125: 1401-1412 [PMID: 7782892]
19. Spiller R. Review article: probiotics and prebiotics in irritable bowel syndrome. Aliment Pharmacol Ther 2008; 28: 385-396 [PMID: 18532993 DOI: 10.1111/j.1365-2036.2008.03750.x]
20. Satokari RM, Vaughan EE, Akkermans AD, Saarela M, De Vos WM. Polymerase chain reaction and denaturing gradient gel electrophoresis monitoring of fecal bifidobacterium populations in a prebiotic and probiotic feeding trial. Syst Appl Microbiol 2001; 24: 227-231 [PMID: 11518325 DOI: 10.1078/0723-2020-00035]
21. Malinen E, Rinttilä T, Kajander K, Mättö J, Kassinen A, Krogius L, Saarela M, Korpela R, Palva A. Analysis of the fecal microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005; 100: 373-382 [PMID: 15667495 DOI: 10.1111/ j.1572-0241.2005.40312.x]
22. Malinen E, Krogius-Kurikka L, Lyra A, Nikkilä J, Jääskeläinen A, Rinttilä T, Vilpponen-Salmela T, von Wright AJ, Palva A. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol 2010; 16: 4532-4540 [PMID: 20857523 DOI: 10.3748/wjg.v16.i36.4532]
23. Bouhnik Y, Attar A, Joly FA, Riottot M, Dyard F, Flourié B. Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans. Eur J Clin Nutr 2004; 58: 462-466 [PMID: 14985684 DOI: 10.1038/ sj.ejcn.1601829]
24. Florent C, Flourie B, Leblond A, Rautureau M, Bernier JJ, Rambaud JC. Influence of chronic lactulose ingestion on the colonic metabolism of lactulose in man (an in vivo study). J Clin Invest 1985; 75: 608-613 [PMID: 3973020 DOI: 10.1172/ JCI111738]
25. Oufir LE, Barry JL, Flourié B, Cherbut C, Cloarec D, Bornet F, Galmiche JP. Relationships between transit time in man and in vitro fermentation of dietary fiber by fecal bacteria. Eur J Clin Nutr 2000; 54: 603-609 [PMID: 10951507 DOI: 10.1038/ sj.ejcn.1600687]
26. Whelan K. Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews. Curr Opin Clin Nutr Metab Care 2011; 14: 581-587 [PMID: 21892075 DOI: 10.1097/ MCO.0b013e32834b8082]
27. Carbohydrate and dietary fiber. In: Kleinman RE, editor. Pediatric nutrition handbook. 4th ed. Elk Grove Village, Il: American Academy of Pediatrics, 1998: 203-211
28. Williams CL, Bollella M, Wynder EL. A new recommendation for dietary fiber in childhood. Pediatrics 1995; 96: 985-988 [PMID: 7494677]
29. Stone AA, Shiffman S, Schwartz JE, Broderick JE, Hufford MR. Patient non-compliance with paper diaries. BMJ 2002; 324: 1193-1194 [PMID: 12016186]
30. Kelley JM, Lembo AJ, Ablon JS, Villanueva JJ, Conboy LA, Levy R, Marci CD, Kerr CE, Kirsch I, Jacobson EE, Riess H, Kaptchuk TJ. Patient and practitioner influences on the placebo effect in irritable bowel syndrome. Psychosom Med 2009; 71: 789-797 [PMID: 19661195 DOI: 10.1097/ PSY.0b013e3181acee12]
31. Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, Veldhuyzen van Zanten SJ. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006; 130: 1538-1551 [PMID: 16678567 DOI: 10.1053/ j.gastro.2005.11.058]